Explore key messages and supporting factoids about the Greater Philadelphia Region’s leadership in Cell and Gene Therapy and Connected Health in this one-sheet document.
The Cell and Gene Therapy and Connected Health Tool Kit is a living resource centered on the Greater Philadelphia region’s past, present and future as a hub for cell and gene therapy and connected health.
Dr. James Wilson and his team at Penn Medicine are celebrating the U.S. Food and Drug Administration (FDA) of a gene therapy known as Zolgensma for Spinal Muscular Atrophy, based on a delivery vehicle that his team discovered and developed over the past decade as part of a wide-ranging portfolio of research to advance gene therapy.
Cancer-therapy firm Iovance Biotherapeutics Inc. plans to open a sprawling office and laboratory complex in South Philadelphia’s Navy Yard complex, adding to the city’s growing clout as a biotechnology research-and-development hub.
Spark Therapeutics Inc., founded by researchers from Children’s Hospital of Philadelphia agreed to be sold to Switzerland-based Roche Holding AG for $4.3 billion.